Quick Search:

Randomised clinical trial: Combined impact and resistance training in adults with stable Crohn’s disease

Jones, Katherine, Baker, Katherine, Speight, R. Ally, Thompson, Nicholas P. and Tew, Garry ORCID logoORCID: https://orcid.org/0000-0002-8610-0613 (2020) Randomised clinical trial: Combined impact and resistance training in adults with stable Crohn’s disease. Alimentary Pharmacology & Therapeutics, 52 (6). pp. 964-975.

[thumbnail of Aliment Pharmacol Ther - 2020 - Jones - Randomised clinical trial  combined impact and resistance training in adults with.pdf]
Preview
Text
Aliment Pharmacol Ther - 2020 - Jones - Randomised clinical trial combined impact and resistance training in adults with.pdf - Published Version
Available under License Creative Commons Attribution.

| Preview

Abstract

Background
Crohn's disease (CD) is a predisposing factor for bone loss and muscle dysfunction, which could lead to osteoporotic fractures and physical disability, respectively.

Aim
To assess the effect of 6 months of combined impact and resistance training on bone mineral density (BMD) and muscle function in adults with CD.

Methods
In this randomised controlled trial, 47 adults with stable CD were assigned to exercise (n = 23) or control (n = 24) groups and followed up for 6 months. The exercise group received usual care plus a 6-month combined impact and resistance training programme, involving three, 60-minute sessions per week and a gradual tapering of supervision to self-management. The control group received usual care alone. The primary outcomes were BMD (via dual energy X-ray absorptiometry) and muscle function (measures of upper and lower limb strength and endurance) at 6 months.

Results
At 6 months, BMD values were superior in the exercise group with statistical significance at lumbar spine (adjusted mean difference 0.036 g/cm2, 95% CI 0.024-0.048; P < 0.001), but not at femoral neck (0.018 g/cm2, 0.001-0.035; P = 0.059) or greater trochanter (0.013 g/cm2, −0.019 to 0.045; P = 0.415) after correcting for multiple outcomes. The exercise group also had superior values for all muscle function outcomes (P < 0.001; unadjusted mean differences ranging 22.6‒48.2%), and lower fatigue severity (P = 0.005). Three exercise-related adverse events were recorded: two instances of light-headedness and one of nausea.

Conclusions
The intervention improved BMD and muscle function in adults with CD and appears as a suitable model of exercise for reducing future risk of osteoporotic fractures and disability.

Trial registration: ISRCTN11470370.

Item Type: Article
Status: Published
DOI: 10.1111/apt.16002
School/Department: School of Science, Technology and Health
URI: https://ray.yorksj.ac.uk/id/eprint/6824

University Staff: Request a correction | RaY Editors: Update this record